McKesson Beats Antitrust-Linked Derivative Suit, For Now
A California federal judge said Tuesday that the executives and directors of pharmaceutical wholesaler McKesson won't have to face a shareholder's derivative class action alleging they shirked their responsibilities by letting...To view the full article, register now.
Already a subscriber? Click here to view full article